Legislators
Bills
Statements
Lobbying
Travel
Searching...- Lobbying
- Lobbying by EveryLife Foundation for Rare Diseases
Lobbying Relationship
Bills mentioned
H.R.1223: OPEN Act
Sponsor: Gus Bilirakis (R-Fla.)
S.1509: Orphan Products Extension Now Accelerating Cures and Treatments Act of 2017
Sponsor: Orrin G. Hatch (R-Utah)
H.R.971: Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2015
Sponsor: Gus Bilirakis (R-Fla.)
S.1421: Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2015
Sponsor: Orrin G. Hatch (R-Utah)
H.R.6: 21st Century Cures Act
Sponsor: Fred Upton (R-Mich.)
H.R.5750: Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2014
Sponsor: Gus Bilirakis (R-Fla.)
H.R.3737: ULTRA
Sponsor: Cliff Stearns (R-Fla.)
H.R.4132: FAST Act
Sponsor: Cliff Stearns (R-Fla.)
S.3187: Food and Drug Administration Safety and Innovation Act
Sponsor: Tom Harkin (D-Iowa)
H.R.5661: To suspend temporarily the rate of duty on 1-Hydroxy cyclohexyl phenyl...
Sponsor: Jo Bonner (R-Ala.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
| Lobbyist | Covered positions? |
|---|---|
| Harry Sporidis | LA, Reps. E.C. Shaw, M. Bilirakis; Sr. LA, Rep. J. Greenwood |
| Rob Daley | LA, Sen. John Barrasso |
| Tim Perrin | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate